会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明授权
    • βig-h3의 일부 도메인을 이용한 세포 부착 및 창상치유 방법
    • βig-h3的任何功能都可以使用本网站的任何内容
    • KR100385293B1
    • 2003-05-23
    • KR1020000025662
    • 2000-05-13
    • (주)리젠바이오텍
    • 김인산김정은
    • A61K38/17
    • C07K14/78A61K38/00
    • The present invention relates to a method for cell adhesion and wound healing with internal domains of betaig-h3. Particularly, the present invention relates to the method of using recombinant proteins comprising one or more of 2 nd or 4 th internal domain of betaig-h3 for cell adhesion and wound healing, wherein the 2 nd or 4 th internal domain of betaig-h3 has aspartic acid and isoleucine essential for interaction with integrin which represent a high homology in base sequence of betaig-h3 internal domains. The recombinant proteins comprising one or more 2 nd or 4 th internal domain of betaig-h3 are effective for cell adhesion and wound healing by itself and can be used for developing cell culture medium and wound healing agent.
    • 本发明涉及用βig-h3的内部结构域进行细胞粘附和伤口愈合的方法。 具体而言,本发明涉及使用包含一种或多种βig-h3内部结构域的2 SUP或SUP内部结构域用于细胞粘附和伤口的重组蛋白的方法 其中,βig-h3的2 SUP内禀结构域或4 SUP结构域的内部结构域具有天冬氨酸和异亮氨酸,它们与整联蛋白相互作用是必需的,这在整个蛋白质的碱基序列中具有高度同源性 betaig-h3内部域。 包含一个或多个betaig-h3的2 SUP内部结构域的重组蛋白质本身对细胞粘附和伤口愈合是有效的,并且可用于开发 细胞培养基和伤口愈合剂。
    • 3. 发明授权
    • 세포 부착, 확산 및 탈착 활성을 나타내는 펩타이드 및그의 유도체
    • 세포부착,확산및탈착활성을나타내,펩타이드및그의유도체
    • KR100378949B1
    • 2003-04-08
    • KR1020000025665
    • 2000-05-13
    • (주)리젠바이오텍
    • 김인산김정은
    • C07K7/00
    • A61K38/08C07K7/06C07K14/4718C07K14/78
    • The present invention relates to peptides and derivatives thereof showing cell attachment, spreading and detachment activity. Particularly, the present invention relates to the peptide NKDIL and EPDIM and derivatives thereof which promote the cell attachment activity through interaction with a alpha 3beta 1 integrin as a functional cell receptor and include aspartic acid and isoleucine essential for cell attachment and detachment activity. The peptides and derivatives thereof in the present invention can be used for developing a study of cell attachment activity mediated through various extracellular matrix protein containing beta ig-h3, wound healing, tissue regeneration and metastasis inhibition.
    • 本发明涉及显示细胞附着,扩散和分离活性的肽及其衍生物。 特别地,本发明涉及通过与作为功能细胞受体的αβ1整联蛋白相互作用来促进细胞附着活性的肽NKDIL和EPDIM及其衍生物,并且包括对于细胞附着和分离活性必需的天冬氨酸和异亮氨酸。 本发明中的肽和其衍生物可用于开发通过各种含有βig-h3的细胞外基质蛋白介导的细胞附着活性,伤口愈合,组织再生和转移抑制的研究。
    • 4. 发明授权
    • 재조합 βig-h3 단백질 및 그 제조방법
    • 재조합βig-h3단백질및그제조방법
    • KR100388935B1
    • 2003-06-25
    • KR1020000025664
    • 2000-05-13
    • (주)리젠바이오텍
    • 김인산김정은
    • C07K14/00
    • PURPOSE: Provided are recombinant protein βig-h3 and a method for manufacturing the purified protein in a high yield which is useful in preventing tumors from developing and in expediting the recovery of damaged skins by using E. coli as a host. CONSTITUTION: A recombinant protein βig-h3 has 237-377 or 498-637 amino acid sequence of natural βig-h3. And a method for manufacturing the recombinant protein βig-h3 comprises the following steps of: i) manufacturing cDNA segment including both a nucleotide coding a selected marker and another nucleotide coding whole or part amino acids of 1-653 amino acid sequence, 237-377 amino acid sequence, or 498-637 amino acid sequence; ii) manufacturing an expression vector having the DNA segments; iii) transforming E. coli with the expression vector; iv) expressing protein in the transformant; and v) purifying the protein by using a selected marker and producing the protein in a high yield.
    • 目的:提供重组蛋白和β-h3以及以高产率制备纯化蛋白质的方法,该方法可用于预防肿瘤发展,并通过使用大肠杆菌作为宿主加速损伤皮肤的恢复。 构成:重组蛋白&βIg-h3具有237-377或498-637个天然和β-h3氨基酸序列。 制备重组蛋白&β-h3的方法包括以下步骤:i)制备包含编码选定标记的核苷酸和编码1-653个氨基酸序列的全部或部分氨基酸的另一核苷酸的cDNA片段 ,237-377个氨基酸序列或498-637个氨基酸序列; ii)制造具有DNA区段的表达载体; iii)用表达载体转化大肠杆菌; iv)在转化体中表达蛋白质; 和v)通过使用选择的标记纯化蛋白质并以高产率生产蛋白质。
    • 6. 发明公开
    • 재조합 βig-h3 단백질 및 그 제조방법
    • 重组蛋白IG-H3及其制备方法
    • KR1020010039603A
    • 2001-05-15
    • KR1020000025664
    • 2000-05-13
    • (주)리젠바이오텍
    • 김인산김정은
    • C07K14/00
    • C07K14/47C12N15/70C12N2510/02C12N2511/00
    • PURPOSE: Provided are recombinant protein βig-h3 and a method for manufacturing the purified protein in a high yield which is useful in preventing tumors from developing and in expediting the recovery of damaged skins by using E. coli as a host. CONSTITUTION: A recombinant protein βig-h3 has 237-377 or 498-637 amino acid sequence of natural βig-h3. And a method for manufacturing the recombinant protein βig-h3 comprises the following steps of: i) manufacturing cDNA segment including both a nucleotide coding a selected marker and another nucleotide coding whole or part amino acids of 1-653 amino acid sequence, 237-377 amino acid sequence, or 498-637 amino acid sequence; ii) manufacturing an expression vector having the DNA segments; iii) transforming E. coli with the expression vector; iv) expressing protein in the transformant; and v) purifying the protein by using a selected marker and producing the protein in a high yield.
    • 目的:提供重组蛋白βig-h3和以高产率制备纯化蛋白质的方法,其可用于预防肿瘤发展和通过使用大肠杆菌作为宿主加速损伤的皮肤的恢复。 构成:重组蛋白βig-h3具有天然βig-h3的237-377或498-637个氨基酸序列。 制备重组蛋白βig-h3的方法包括以下步骤:i)制备cDNA片段,其包含编码所选标记的核苷酸和编码1-653个氨基酸序列的全部或部分氨基酸的另一核苷酸,237-377 氨基酸序列或498-637氨基酸序列; ii)制备具有DNA片段的表达载体; iii)用表达载体转化大肠杆菌; iv)在转化体中表达蛋白质; 和v)通过使用所选择的标记并以高产率产生蛋白来纯化蛋白质。